Titan's robotic surgical system, currently under development, comprises a surgeon-controlled single incision platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments providing a 3D endoscopic view of inside a patient’s body during MIS procedures.
The robotic surgical system is being developed with the objective of delivering multiple benefits to surgeons, including:
• Single incision access for the 3D vision system and the instruments
• Precision, control and range of motion of micro-instruments
• Improved access to organs, tissues and nerves with high dexterity instruments
• Magnified 3D vision for anatomic viewing
Single Incision platform:
The single incision platform is being developed with the goal of providing interactive instruments and a 3D vision system capable of being inserted into the patient’s body cavity through a single incision. The design contemplates a collapsible device that, when collapsed, would be capable of being inserted into the patient’s body cavity through a skin incision of approximately 25mm. Once inserted, the device is configured to deploy into a working configuration whereby the 3D vision system and interactive instruments would be capable of being controlled by a surgeon at the workstation.
The Company has ownership of serval U.S. patents and patent applications filed in the U.S. or under the Patent Cooperation Treaty (PCT). Additionally, the Company holds exclusive rights to patent applications presently pending before patent offices in the U.S., Canada or Europe.